36E79724R0010_1.docx

DOCX document 17 KB Posted

Attached to
6505--Carbamazepine 200MG Tablets Federal contract opportunity
Solicitation number
36E79724R0010
Issued by
Department of Veterans Affairs National Acquisition Center

About this file

This presolicitation notice is for a one-year contract with four option years to supply Carbamazepine 200MG tablets to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Interested offerors must provide the tablets with packaging sizes of either 100 tablets per bottle or 1000 tablets per bottle. The estimated annual quantities required are 7,553 bottles of the 100 tablet size and 9,921 bottles of the 1000 tablet size. The solicitation number is 36E79724R0010 and will be issued on February 6, 2024 electronically through FAR Part 12 for commercial items. Final offers are due by February 20, 2024. The contracting office is the VA National Acquisition Center and point of contact is Richard Mahario. Once awarded, this contract will mandate the use of generic Carbamazepine tablets, though providers can still prescribe the branded Tegretol product if deemed clinically necessary.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Presolicitation Notice Presolicitation Notice

SUBJECT*
Carbamazepine 200MG Tablets

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
60141
SOLICITATION NUMBER*
36E79724R0010
RESPONSE DATE/TIME/ZONE
02-20-2024 14:30 CENTRAL TIME, CHICAGO, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

PLACE OF PERFORMANCE

POSTAL CODE

COUNTRY

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

OPAL/National Acquisition Center Building 37, NCS (003B6C3) 1st Avenue, One Block North of Cermak 60141

POINT OF CONTACT*

Contract Specialist Richard Mahario Richard.Mahario@va.gov 708-786-5247

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
Richard.Mahario@va.gov
EMAIL DESCRIPTION
Contracting Officer

DESCRIPTION

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0010 for an unrestrictive procurement for Carbamazepine 200MG Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79724R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 6, 2024, with a tentative closing date of February 20, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to: Richard.Mahario@va.gov

The estimated annual requirements are as follows:

ITEM
DESCRIPTION
PACKAGE SIZE (TABLETS PER BOTTLES)
TOTAL ESTIMATED ANNUAL USAGE (BOTTLES)
1
CARBAMAZEPINE 200MG TABLETS
100
7,553
2
CARBAMAZEPINE 200MG TABLETS
1000
9,921

Note: Once awarded, this contract will be mandatory for use of the generic version of Carbamazepine Tablets. Agencies will have the ability to continue to prescribe the branded product Tegretol®, for patients where the provider has determined a generic product is NOT clinically appropriate.

*=Required Field
Presolicitation Notice

Presolicitation Notice

File details come from the government source that posted it. Updated .